NCT06146101

RePOSA-Revealing the Efficacy of IHL-42X Use in Patients With OSA

CompletedPHASE2, PHASE3INTERVENTIONAL

Trial Details

Start: 2024-05-02Est. Completion: 2025-05-20

Enrollment target: 121 participants

Locations

Exalt Clinical Research, Chula Vista, California, United States
CenExel CNS- Los Alamitos, Long Beach, California, United States
Pacific Clinical Research Medical Group, Upland, California, United States
Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Jacksonville), Jacksonville, Florida, United States
Clinical Neuroscience Solutions, Inc. (CNS Healthcare of Orlando), Orlando, Florida, United States
Teradan Clinical Trials, Valrico, Florida, United States
Palm Beach Research Center, West Palm Beach, Florida, United States
NeuroTrials Research, Inc., Atlanta, Georgia, United States
Tandem Clinical Research, LLC, Marrero, Louisiana, United States
Centennial Medical Group, Elkridge, Maryland, United States
Meridian Clinical Research, LLC, Rockville, Maryland, United States
Henderson Clinical Trials,LLC, Henderson, Nevada, United States
Advanced Respiratory and Sleep Medicine, PLLC, Huntersville, North Carolina, United States
CTI Clinical Trial and Consulting Services, Cincinnati, Ohio, United States
Intrepid Research, Cincinnati, Ohio, United States

Obstructive Sleep Apnea (OSA)

The goal of this randomized, double-blind, multi-dose crossover clinical trial is to determine the safety and efficacy o…

Chula Vista, United StatesEst. completion Apr 2027

Acute Respiratory Distress Syndrome (ARDS)s100bMechanical PowerVentilator Induced Lung InjuryTranspulmonary Pressure

Acute respiratory distress syndrome (ARDS) is characterized by pathological pulmonary edema caused by direct or indirect…

Multiple LocationsEst. completion Oct 23, 2028

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.